Showing 1331-1340 of 9844 results for "".
Long-term efficacy and safety data from ILUMYA™ clinical trials
https://practicaldermatology.com/topics/psoriasis/long-term-efficacy-and-safety-data-from-ilumya-clinical-trials/19858/Explore efficacy and safety data for ILUMYA™ from the reSURFACE 1 and reSURFACE 2 Phase 3 trials and extension studies.Six Financial Actions to Take During the COVID-19 Crisis
https://practicaldermatology.com/topics/practice-management/six-financial-actions-to-take-during-the-covid-19-crisis/23293/Tips to help weather the storm and prepare for better days ahead.COVID-19 Coping Strategies
https://practicaldermatology.com/topics/practice-management/covid-19-coping-strategies/19755/Nina Chaifetz, LCSW-R, a licensed clinical social worker and co-founder of Lotus Psychotherapy in New York, offers strategies to use every day to lessen anxiety, especially now as the COVID-19 pandemic continues to disrupt our world and increases feelings of fear, stress, and uncertainty.Marketing trends in 2020 – Dermatology gets more social
https://practicaldermatology.com/topics/practice-management/marketing-trends-in-2020-dermatology-gets-more-social/19712/Social media is the place to be for dermatology practices in the New Year. Check out these tips from Ekwa Marketing (www.ekwa.com) to help you build your following, and your patient base.As Social Media Evolves, Is Your Marketing Strategy Keeping Up?
https://practicaldermatology.com/topics/practice-management/as-social-media-evolves-is-your-marketing-strategy-keeping-up/23119/To click with savvy consumers, be authentic and use social media tools to create true connections.DermWireTV: AbbVie to Acquire Allergan, Duobrii Launches, SDPA at 25
https://practicaldermatology.com/topics/psoriasis/dermwiretv-abbvie-to-acquire-allergan-duobrii-launches-sdpa-at-25/19629/In a deal with an equity value of approximately $63 billion, AbbVie has agreed to acquire Allergan. The new company is positioned for new growth platforms and a diversified revenue base; the deal will be immediately accretive to earnings per share, AbbVie says. The Society of Dermatology Physician ABTL, Sciton Updates; Sun Gets PsO Real
https://practicaldermatology.com/topics/psoriasis/dermwire-tv-btl-sciton-updates-sun-gets-pso-real/19601/BTL rolls out a small Emsculpt applicator to treat arms, thighs and calves at ASLMS. Sciton introduces JOULE X. In conjunction with Sun Pharma, the Association for Applied and Therapeutic Humor is offering strategies to help psoriasis patients navigate emotional challenges and uncomfortable psoriasiHow Outsourcing Services Can Benefit Your Practice: Considerations for a Busy Practice
https://practicaldermatology.com/topics/practice-management/how-outsourcing-services-can-benefit-your-practice-considerations-for-a-busy-practice/20339/Credentialing can be a tedious, time-consuming process. Outsourcing to someone with expertise can help.Coral Reefs Under Siege: Is Sunscreen to Blame?
https://practicaldermatology.com/topics/practice-management/coral-reefs-under-siege-is-sunscreen-to-blame/20543/What the science says about the effects of sunscreens on marine life.Alexa, Re-order My Retin-A STAT
https://practicaldermatology.com/topics/practice-management/alexa-re-order-my-retin-a-stat/20553/And other digital practice headlines we may see in 2018.